Why insider trading matters?

When insiders buy shares on the open market, this can thus be regarded as a strong endorsement by those that know the company the best -- they are literally betting their own money on the company's future. Insider selling, however, is not necessarily meaningful in any way, as there is a range of reasons for insiders to liquidate (some) of the shares they own.

- Seeking Alpha
Corvus Pharmaceuticals, Inc. (CRVS)
Sector: Healthcare; Industry: Biotechnology

Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is CPI-444, an oral, small molecule antagonist of the A2A receptor that is in Phase I/Ib clinical trial for adenosine, an immune checkpoint.

Trade Date Insider Title Buy/Sell #Shares Price Value Option
2020-07-08 Novo Holdings A/S 10%-Owner Sell 1,538,062 $5.31 $8,168,547 No
2019-07-25 Novo Holdings A/S 10%-Owner Sell 1,492,956 $4.07 $6,077,845 No
2018-03-12 Novo Holdings A/S 10%-Owner Buy 1,176,470 $8.50 $9,999,995 No
2017-06-23 Novo Holdings A/S 10%-Owner Buy 20,000 $10.95 $219,000 No
2016-05-12 Novo A/S 10%-Owner Buy 70,000 $10.00 $700,000 No
2016-03-29 Novo A/S 10%-Owner Buy 666,666 $15.00 $9,999,990 Yes

Insider Smart

Axsome Therapeutics, Inc (AXSM) - AXSM shows the power of an #allgreen stock, no insider selling, great management great company, if you follow the insiders last year and pick up around $25, the 52 week high is $100+.